Results 151 to 160 of about 7,548 (263)

Insulin degludec: The new standard long acting insulin analogue for people with type 1 diabetes? [Letter to the Editor]

, 2016
Agust iacute n Aacute ngel Merchante-Alfaro, Susana P eacute rez-Naranjo, Pablo Abellán Galiana, Olalla Rubio-Puchol   +3 more
openalex   +2 more sources

Efficacy and safety of insulin degludec/aspart in patients with type 2 and type 1 diabetes mellitus: real-world evidence from Indonesia. [PDF]

Front Endocrinol (Lausanne)
Zufry H, Sucipto KW, Ekadamayanti AS, Iqbal Q.   +3 more
europepmc   +1 more source

Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. [PDF]

Front Endocrinol (Lausanne), 2023
Alhmoud EN, Saad MO, Omar NE.
europepmc   +1 more source

Current status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials

, 2019
Vanessa Preumont, Martin Buysschaert
openalex   +2 more sources

In-Hospital Management of Hyperglycemia: The Role of Insulin Degludec. [PDF]

Diabetes Ther
Wangnoo SK, Baruah MP, Lodha S, Sanyal D, Goyal R, Sooragonda BG, Chandrasekaran S, Vijay Kumar G.   +7 more
europepmc   +1 more source

No insulin degludec dose adjustment required after aerobic exercise for people with type 1 diabetes: the ADREM study. [PDF]

Diabetologia, 2023
Drenthen LCA, Ajie M, Abbink EJ, Rodwell L, Thijssen DHJ, Tack CJ, de Galan BE.   +6 more
europepmc   +1 more source

Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial [PDF]

, 2012
Yasuhiko Iwamoto, Per Clauson, Tomoyuki Nishida, Kohei Kaku   +3 more
openalex   +1 more source

Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol. [PDF]

Diabetes Obes Metab
Rabbone I, Tinti D, Rigamonti A, Mossetto C, Trada M, de Sanctis L, Abate Daga F, Agostino S, Pistone C, Scaramuzza A, Bonfanti R.   +10 more
europepmc   +1 more source

Insulin allergy successfully managed using a combination of multi-hexamer-forming insulin degludec and vildagliptin-a case report

, 2019
Asim Hassan, Saud Al Sifri, Mohammed Bilal Jaja, Mohammed Motasim Ali Haj Elamin   +3 more
openalex   +1 more source

Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch^® among self-injection-naïve patients with type 2 diabetes mellitus in Japan [PDF]

, 2018
Toshinari Asakura, Shuichi Suzuki, Toshihiko Aranishi, Zhihong Cai   +3 more
openalex   +1 more source